KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $27.9 billion.

  • Novartis Ag's Non-Current Debt rose 3074.51% to $27.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.9 billion, marking a year-over-year increase of 3074.51%. This contributed to the annual value of $27.9 billion for FY2025, which is 3074.51% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Non-Current Debt is $27.9 billion, which was up 3074.51% from $22.6 billion recorded in Q3 2025.
  • Novartis Ag's Non-Current Debt's 5-year high stood at $27.9 billion during Q4 2025, with a 5-year trough of $17.2 billion in Q1 2024.
  • In the last 5 years, Novartis Ag's Non-Current Debt had a median value of $21.9 billion in 2022 and averaged $21.7 billion.
  • Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 1787.06% in 2023, then surged by 3144.79% in 2024.
  • Novartis Ag's Non-Current Debt (Quarter) stood at $22.9 billion in 2021, then decreased by 11.61% to $20.2 billion in 2022, then decreased by 8.93% to $18.4 billion in 2023, then increased by 15.89% to $21.4 billion in 2024, then soared by 30.75% to $27.9 billion in 2025.
  • Its last three reported values are $27.9 billion in Q4 2025, $22.6 billion for Q3 2025, and $22.5 billion during Q2 2025.